Dr. Katherine Loon graduated the medical school from the Medical College of Georgia School of Medicine and completed her residency program at the Beth Israel Deaconess Medical Center. A fellowship followed at the UCSF soon after that. Dr. Loon is specialized in oncology and board certified in internal medicine and medical oncology. She has been in practice for more than 6 years and is affiliated with the San Francisco General Hospital and the UCSF Medical Center. During her career, she has also contributed to numerous publications of medical interest.
Medical College of Georgia
Beth Israel Deaconess Medical Center
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
A phase I first-in-human study of Nesvacumab (REGN910), a fully-human anti-Angiopoietin-2 (Ang2) monoclonal antibody, in patients with advanced solid tumors.
Papadopoulos, K. P.,Kelley, R. K.,Tolcher, A. W.,Abdul Razak, A. R.,Van Loon, K.,Patnaik, A.,Bedard, P. L.,Alfaro, A. A.,Beeram, M.,Adriaens, L.,Brownstein, C. M.,Lowy...; Clin. Cancer Res.. 2015 Oct 23.See more >>
The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?
Cheng, M. L.,Zhang, L.,Borok, M.,Chokunonga, E.,Dzamamala, C.,Korir, A.,Wabinga, H. R.,Hiatt, R. A.,Parkin, D. M.,Van Loon, K.; Cancer Epidemiol. 2015 Feb 11.See more >>
Bone metastases and skeletal-related events from neuroendocrine tumors.
Van Loon, K.,Zhang, L.,Keiser, J.,Carrasco, C.,Glass, K.,Ramirez, M. T.,Bobiak, S.,Nakakura, E. K.,Venook, A. P.,Shah, M. H.,Bergsland, E. K.; Endocr Connect. 2014 Nov 29.See more >>
American Society of Clinical Oncology